ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
83,145
0,46%
Bitcoin
63 785,55
-0,17%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Inhibrx Inc (INBX)

  7. Inhibrx Inc (INBX) Actualités

INBX Inhibrx Inc

34,15
0,14 (0,41%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Inhibrx Inc INBX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,14 0,41% 34,15 23:22:21
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
34,35 33,87 34,45 34,15 34,01
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/3/202421:26EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:08EDGAR2Form 144 - Report of proposed sale of securities
08/3/202421:28EDGAR2Form 144 - Report of proposed sale of securities
06/3/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:58EDGAR2Form 144 - Report of proposed sale of securities
05/3/202400:26EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
28/2/202415:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
28/2/202415:12EDGAR2Form 8-K - Current report
28/2/202415:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
14/2/202422:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202422:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202418:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
23/1/202423:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202412:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/1/202412:35EDGAR2Form 8-K - Current report
23/1/202412:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202411:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202407:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
09/11/202322:03EDGAR2Form 8-K - Current report
09/11/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
02/11/202314:16EDGAR2Form 8-K - Current report
02/11/202314:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
18/10/202322:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
19/9/202322:03EDGAR2Form 8-K - Current report
19/9/202322:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
31/8/202322:06EDGAR2Form D - Notice of Exempt Offering of Securities
29/8/202315:03EDGAR2Form 8-K - Current report
29/8/202315:00PRNUSInhibrx Announces $200 Million Private Placement Financing
07/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202322:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
30/5/202315:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
30/5/202315:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
08/5/202322:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
INBX
Inhibrx
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés